TY - JOUR
AU - Alvarez-Lerma, Francisco
AB - Correspondence References Table 1. Patient characteristics at admission to the intensive care unit and at the beginning of linezolid treatment 1. Bonnet R. Growing group of extended-spectrum b-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1–14. Mean 2. Weill FX, Perrier-Gros-Claude JD, Demartin M et al. Characterization of extended-spectrum-b-lactamase (CTX-M-15)-producing strains of Age (years) 63.4 (95%CI 58.9–67.9) Salmonella enterica isolated in France and Senegal. FEMS Microbiol Lett 2004; 238: 353–8. Simplified Acute Physiologic 54.9 (95%CI 47.9–62.0) 3. Boualle ` gue-Godet O, Ben Salem Y, Fabre L et al. Nosocomial Score II outbreak caused by Salmonella enterica serotype Livingstone producing Laboratory values at the beginning of linezolid treatment CTX-M-27 extended-spectrum b-lactamase in a neonatal unit in Sousse, platelet count (10 cells/mL) 326.4 (95%CI 227.1–375.7) Tunisia. J Clin Microbiol 2005; 43: 1037–44. albumin (g/100 mL) 2.4 (95%CI 2.2–2.6) 4. Lartigue MF, Poirel L, Decousser JW et al. Multidrug-resistant creatinine (mg/100 mL) 1.5 (95%CI 1.1–1.9) Shigella sonnei and Salmonella enterica serotype Typhimurium isolates blood urea nitrogen (mg/100 mL) 40.4 (95%CI 29.5–51.3) producing CTX-M b-lactamases as causes of community-acquired calculated glomerular filtration 64.4 (95%CI 52.2–76.5) infection in France. Clin Infect Dis 2005; 40: 1069–70. rate (mL/min/1.73 m ) 5. Jacoby GA, Han 
TI - Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopenia
JF - Journal of Antimicrobial Chemotherapy
DO - 10.1093/jac/dki202
DA - 2005-08-14
UR - https://www.deepdyve.com/lp/oxford-university-press/linezolid-low-pre-treatment-platelet-values-could-increase-the-risk-of-VMQoQFmLFl
SP - 440
EP - 441
VL - 56
IS - 2
DP - DeepDyve
ER -